XML 22 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Investment in LipoMedix (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 30, 2020
Nov. 30, 2019
Apr. 30, 2019
Mar. 31, 2018
Jan. 31, 2020
LipoMedix [Member]          
Investment in LipoMedix (Textual)          
No-interest bridge financing         $ 875,000
LipoMedix [Member] | Minimum [Member]          
Investment in LipoMedix (Textual)          
Ownership Percentage         52.10%
LipoMedix [Member] | Maximum [Member]          
Investment in LipoMedix (Textual)          
Ownership Percentage         57.90%
LipoMedix [Member]          
Investment in LipoMedix (Textual)          
Issued and outstanding ordinary shares, percentage       57.90%  
Description of acquisition entity The Company provided bridge financing in the principal amount of $125,000 to LipoMedix with a maturity date of May 3, 2020. The Company provided bridge financing in the principal amount of $100,000 to LipoMedix with a maturity date of May 3, 2020. The Company provided no-interest bridge financing of $250,000 to LipoMedix (the "2019 Bridge Note"). The 2019 Bridge Note converted into 471,698 shares of LipoMedix on September 28, 2019 which increased the Company's ownership on that date from 50.6% to 52.1%.    
Bridge Note Converted         1,650,943